Chapter/Section Purchase

1 Study Coverage
1.1 Immuno-oncology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Immuno-oncology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Immune System Modulators
1.2.4 Cancer Vaccines
1.2.5 Oncolytic Virus
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-oncology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Immuno-oncology Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Immuno-oncology Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Immuno-oncology Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Immuno-oncology Drugs Sales by Region
2.4.1 Global Immuno-oncology Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Immuno-oncology Drugs by Region (2023-2028)
2.5 Global Immuno-oncology Drugs Revenue by Region
2.5.1 Global Immuno-oncology Drugs Revenue by Region (2017-2022)
2.5.2 Global Immuno-oncology Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Immuno-oncology Drugs Sales by Manufacturers
3.1.1 Global Top Immuno-oncology Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Immuno-oncology Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immuno-oncology Drugs in 2021
3.2 Global Immuno-oncology Drugs Revenue by Manufacturers
3.2.1 Global Immuno-oncology Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Immuno-oncology Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Immuno-oncology Drugs Revenue in 2021
3.3 Global Immuno-oncology Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Immuno-oncology Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Immuno-oncology Drugs Sales by Type
4.1.1 Global Immuno-oncology Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Immuno-oncology Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
4.2 Global Immuno-oncology Drugs Revenue by Type
4.2.1 Global Immuno-oncology Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Immuno-oncology Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Immuno-oncology Drugs Price by Type
4.3.1 Global Immuno-oncology Drugs Price by Type (2017-2022)
4.3.2 Global Immuno-oncology Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Immuno-oncology Drugs Sales by Application
5.1.1 Global Immuno-oncology Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Immuno-oncology Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Immuno-oncology Drugs Sales Market Share by Application (2017-2028)
5.2 Global Immuno-oncology Drugs Revenue by Application
5.2.1 Global Immuno-oncology Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Immuno-oncology Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Immuno-oncology Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Immuno-oncology Drugs Price by Application
5.3.1 Global Immuno-oncology Drugs Price by Application (2017-2022)
5.3.2 Global Immuno-oncology Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Immuno-oncology Drugs Market Size by Type
6.1.1 North America Immuno-oncology Drugs Sales by Type (2017-2028)
6.1.2 North America Immuno-oncology Drugs Revenue by Type (2017-2028)
6.2 North America Immuno-oncology Drugs Market Size by Application
6.2.1 North America Immuno-oncology Drugs Sales by Application (2017-2028)
6.2.2 North America Immuno-oncology Drugs Revenue by Application (2017-2028)
6.3 North America Immuno-oncology Drugs Market Size by Country
6.3.1 North America Immuno-oncology Drugs Sales by Country (2017-2028)
6.3.2 North America Immuno-oncology Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Immuno-oncology Drugs Market Size by Type
7.1.1 Europe Immuno-oncology Drugs Sales by Type (2017-2028)
7.1.2 Europe Immuno-oncology Drugs Revenue by Type (2017-2028)
7.2 Europe Immuno-oncology Drugs Market Size by Application
7.2.1 Europe Immuno-oncology Drugs Sales by Application (2017-2028)
7.2.2 Europe Immuno-oncology Drugs Revenue by Application (2017-2028)
7.3 Europe Immuno-oncology Drugs Market Size by Country
7.3.1 Europe Immuno-oncology Drugs Sales by Country (2017-2028)
7.3.2 Europe Immuno-oncology Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Immuno-oncology Drugs Market Size by Type
8.1.1 Asia Pacific Immuno-oncology Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Immuno-oncology Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Immuno-oncology Drugs Market Size by Application
8.2.1 Asia Pacific Immuno-oncology Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Immuno-oncology Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Immuno-oncology Drugs Market Size by Region
8.3.1 Asia Pacific Immuno-oncology Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Immuno-oncology Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Immuno-oncology Drugs Market Size by Type
9.1.1 Latin America Immuno-oncology Drugs Sales by Type (2017-2028)
9.1.2 Latin America Immuno-oncology Drugs Revenue by Type (2017-2028)
9.2 Latin America Immuno-oncology Drugs Market Size by Application
9.2.1 Latin America Immuno-oncology Drugs Sales by Application (2017-2028)
9.2.2 Latin America Immuno-oncology Drugs Revenue by Application (2017-2028)
9.3 Latin America Immuno-oncology Drugs Market Size by Country
9.3.1 Latin America Immuno-oncology Drugs Sales by Country (2017-2028)
9.3.2 Latin America Immuno-oncology Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Immuno-oncology Drugs Market Size by Type
10.1.1 Middle East and Africa Immuno-oncology Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Immuno-oncology Drugs Market Size by Application
10.2.1 Middle East and Africa Immuno-oncology Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Immuno-oncology Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Immuno-oncology Drugs Market Size by Country
10.3.1 Middle East and Africa Immuno-oncology Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Immuno-oncology Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen, Inc
11.1.1 Amgen, Inc Corporation Information
11.1.2 Amgen, Inc Overview
11.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen, Inc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen, Inc Recent Developments
11.2 AstraZeneca, Plc
11.2.1 AstraZeneca, Plc Corporation Information
11.2.2 AstraZeneca, Plc Overview
11.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca, Plc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca, Plc Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Celgene Corporation
11.4.1 Celgene Corporation Corporation Information
11.4.2 Celgene Corporation Overview
11.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Celgene Corporation Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Celgene Corporation Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Overview
11.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly and Company Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly and Company Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Corporation Information
11.6.2 Merck & Co. Overview
11.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merck & Co. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck & Co. Recent Developments
11.7 Hoffmann-La Roche AG
11.7.1 Hoffmann-La Roche AG Corporation Information
11.7.2 Hoffmann-La Roche AG Overview
11.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hoffmann-La Roche AG Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson Recent Developments
11.9 Novartis International AG
11.9.1 Novartis International AG Corporation Information
11.9.2 Novartis International AG Overview
11.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis International AG Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis International AG Recent Developments
11.10 AbbVie, Inc.
11.10.1 AbbVie, Inc. Corporation Information
11.10.2 AbbVie, Inc. Overview
11.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AbbVie, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AbbVie, Inc. Recent Developments
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Corporation Information
11.11.2 Pfizer Inc. Overview
11.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Pfizer Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pfizer Inc. Recent Developments
11.12 Sanofi S.A.
11.12.1 Sanofi S.A. Corporation Information
11.12.2 Sanofi S.A. Overview
11.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Sanofi S.A. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sanofi S.A. Recent Developments
11.13 EMD Serono, Inc.
11.13.1 EMD Serono, Inc. Corporation Information
11.13.2 EMD Serono, Inc. Overview
11.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 EMD Serono, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 EMD Serono, Inc. Recent Developments
11.14 Gilead Sciences Inc.
11.14.1 Gilead Sciences Inc. Corporation Information
11.14.2 Gilead Sciences Inc. Overview
11.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Gilead Sciences Inc. Recent Developments
11.15 Prometheus Therapeutics & Diagnostics
11.15.1 Prometheus Therapeutics & Diagnostics Corporation Information
11.15.2 Prometheus Therapeutics & Diagnostics Overview
11.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Prometheus Therapeutics & Diagnostics Recent Developments
11.16 Aduro BioTech
11.16.1 Aduro BioTech Corporation Information
11.16.2 Aduro BioTech Overview
11.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Aduro BioTech Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Aduro BioTech Recent Developments
11.17 Galena Biopharma
11.17.1 Galena Biopharma Corporation Information
11.17.2 Galena Biopharma Overview
11.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Galena Biopharma Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Galena Biopharma Recent Developments
11.18 Bavarian Nordic
11.18.1 Bavarian Nordic Corporation Information
11.18.2 Bavarian Nordic Overview
11.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Bavarian Nordic Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Bavarian Nordic Recent Developments
11.19 Celldex Therapeutics
11.19.1 Celldex Therapeutics Corporation Information
11.19.2 Celldex Therapeutics Overview
11.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Celldex Therapeutics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Celldex Therapeutics Recent Developments
11.20 ImmunoCellular Therapeutics
11.20.1 ImmunoCellular Therapeutics Corporation Information
11.20.2 ImmunoCellular Therapeutics Overview
11.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 ImmunoCellular Therapeutics Recent Developments
11.21 Incyte
11.21.1 Incyte Corporation Information
11.21.2 Incyte Overview
11.21.3 Incyte Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Incyte Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Incyte Recent Developments
11.22 Dendreon Corporation
11.22.1 Dendreon Corporation Corporation Information
11.22.2 Dendreon Corporation Overview
11.22.3 Dendreon Corporation Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Dendreon Corporation Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Dendreon Corporation Recent Developments
11.23 Agilent Technologies Inc.
11.23.1 Agilent Technologies Inc. Corporation Information
11.23.2 Agilent Technologies Inc. Overview
11.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Agilent Technologies Inc. Recent Developments
11.24 Agenus Inc.
11.24.1 Agenus Inc. Corporation Information
11.24.2 Agenus Inc. Overview
11.24.3 Agenus Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Agenus Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Agenus Inc. Recent Developments
11.25 Enzo Biochem, Inc.
11.25.1 Enzo Biochem, Inc. Corporation Information
11.25.2 Enzo Biochem, Inc. Overview
11.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Enzo Biochem, Inc. Recent Developments
11.26 Lonza Group
11.26.1 Lonza Group Corporation Information
11.26.2 Lonza Group Overview
11.26.3 Lonza Group Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Lonza Group Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Lonza Group Recent Developments
11.27 Bio-Rad Laboratories, Inc.
11.27.1 Bio-Rad Laboratories, Inc. Corporation Information
11.27.2 Bio-Rad Laboratories, Inc. Overview
11.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Bio-Rad Laboratories, Inc. Recent Developments
11.28 Avantor, Inc.
11.28.1 Avantor, Inc. Corporation Information
11.28.2 Avantor, Inc. Overview
11.28.3 Avantor, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.28.4 Avantor, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Avantor, Inc. Recent Developments
11.29 Spring Bank Pharmaceuticals, Inc.
11.29.1 Spring Bank Pharmaceuticals, Inc. Corporation Information
11.29.2 Spring Bank Pharmaceuticals, Inc. Overview
11.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Spring Bank Pharmaceuticals, Inc. Recent Developments
11.30 Ferring Pharmaceuticals
11.30.1 Ferring Pharmaceuticals Corporation Information
11.30.2 Ferring Pharmaceuticals Overview
11.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.30.5 Ferring Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Immuno-oncology Drugs Industry Chain Analysis
12.2 Immuno-oncology Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immuno-oncology Drugs Production Mode & Process
12.4 Immuno-oncology Drugs Sales and Marketing
12.4.1 Immuno-oncology Drugs Sales Channels
12.4.2 Immuno-oncology Drugs Distributors
12.5 Immuno-oncology Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Immuno-oncology Drugs Industry Trends
13.2 Immuno-oncology Drugs Market Drivers
13.3 Immuno-oncology Drugs Market Challenges
13.4 Immuno-oncology Drugs Market Restraints
14 Key Findings in The Global Immuno-oncology Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer